Category Archives: Others

Covid-19 outbreak worsens in Latin America as Argentina, Ecuador report deaths   Venezuela, Uruguay, Guatemala and Suriname reported their first cases of the Covid-19 pandemic. Overall cases in the region have more than doubled in the last two days to over 340 as the Pan American Health Organisation (PAHO) warned governments on Thursday to prepare […]

Trudeau closes Canadian borders to most foreign travellers amid coronavirus outbreak   Prime Minister Justin Trudeau announced on Monday that Canada will be closing its borders to most foreign travellers in an attempt to limit the spread of the novel coronavirus. Speaking to reporters from Rideau Cottage in Ottawa, Trudeau said Canada is taking “increasingly aggressive steps” and will […]

Businesses Face a New Coronavirus Threat: Shrinking Access to Credit Large and small businesses, which borrow heavily threat   Businesses affected by COVID-19: Provide customers with updated info If your business is affected by COVID-19, update your Google My Business profile to provide the most accurate information to your customers. For example, change your hours […]

Coronavirus Disease (COVID-19) – Statistics and Research   Limitations of current research and limitations of our presentation of current research The purpose of this article on COVID-19 is to aggregate existing research, bring together the relevant data and allow readers to make sense of the published data and early research on the coronavirus outbreak. Most […]

TRUE or FALSE? A vaccine to cure COVID-19 is available. FALSE. True: There is no vaccine for the new coronavirus right now. Scientists have already begun working on one, but developing a vaccine that is safe and effective in human beings will take many months. TRUE or FALSE? You can protect yourself from COVID-19 by swallowing […]

Coronavirus latest: First vaccine clinical trials begin in the United States The first Phase I clinical trial for a potential COVID-19 vaccine has begun in Seattle, Washington. Four adults, the first of 45 eventual participants, received their first doses of an experimental vaccine developed through a partnership between the US National Institute of Allergy and […]